For: | Maqbool A, Spary EJ, Manfield IW, Ruhmann M, Zuliani-Alvarez L, Gamboa-Esteves FO, Porter KE, Drinkhill MJ, Midwood KS, Turner NA. Tenascin C upregulates interleukin-6 expression in human cardiac myofibroblasts via toll-like receptor 4. World J Cardiol 2016; 8(5): 340-350 [PMID: 27231521 DOI: 10.4330/wjc.v8.i5.340] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v8/i5/340.htm |
Number | Citing Articles |
1 |
Sumia A. Bageghni, Karen E. Hemmings, Nadira Y. Yuldasheva, Azhar Maqbool, Filomena O. Gamboa-Esteves, Neil E. Humphreys, Maj Simonsen Jackson, Christopher P. Denton, Sheila Francis, Karen E. Porter, Justin F.X. Ainscough, Emmanuel Pinteaux, Mark J. Drinkhill, Neil A. Turner. Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction. JCI Insight 2019; 4(17) doi: 10.1172/jci.insight.125074
|
2 |
Jayalakshmi Krishnan, Muhammad Ayaz Anwar, Sangdun Choi. Encyclopedia of Signaling Molecules. 2016; : 1 doi: 10.1007/978-1-4614-6438-9_592-1
|
3 |
Kyoko Imanaka-Yoshida, Isao Tawara, Toshimichi Yoshida. Tenascin-C in cardiac disease: a sophisticated controller of inflammation, repair, and fibrosis. American Journal of Physiology-Cell Physiology 2020; 319(5): C781 doi: 10.1152/ajpcell.00353.2020
|
4 |
Jayalakshmi Krishnan, Muhammad Ayaz Anwar, Sangdun Choi. Encyclopedia of Signaling Molecules. 2017; : 1 doi: 10.1007/978-1-4614-6438-9_592-2
|
5 |
Swati Bhattacharyya, John Varga. Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy. Immunology Letters 2018; 195: 9 doi: 10.1016/j.imlet.2017.09.011
|
6 |
Swati Bhattacharyya, Kim S. Midwood, John Varga. Tenascin-C in fibrosis in multiple organs: Translational implications. Seminars in Cell & Developmental Biology 2022; 128: 130 doi: 10.1016/j.semcdb.2022.03.019
|
7 |
Swati Bhattacharyya, Kim S. Midwood, Hang Yin, John Varga. Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma. Advances in Wound Care 2017; 6(10): 356 doi: 10.1089/wound.2017.0732
|
8 |
Claire E. McQuitty, Roger Williams, Shilpa Chokshi, Luca Urbani. Immunomodulatory Role of the Extracellular Matrix Within the Liver Disease Microenvironment. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.574276
|
9 |
Naveed Pervaiz, Ishita Kathuria, Ravi Varma Aithabathula, Bhupesh Singla. Matricellular proteins in atherosclerosis development. Matrix Biology 2023; 120: 1 doi: 10.1016/j.matbio.2023.04.003
|
10 |
Jayalakshmi Krishnan, Muhammad Ayaz Anwar, Sangdun Choi. Encyclopedia of Signaling Molecules. 2018; : 5472 doi: 10.1007/978-3-319-67199-4_592
|
11 |
L. A. Vozniuk, I. O. Doroshkevych, O. O. Klekоt, O. V. Kyrychenko.
VALUE OF ENDOTHELIUM DYSFUNCTION AND INFLAMMATORY MARKERS LEVEL FOR PREDICTING RISK ASSESSMENT IN UNFAVORABLE COURSE OF ISCHEMIC HEART DISEASE
. World of Medicine and Biology 2019; 15(67): 017 doi: 10.26724/2079-8334-2019-1-67-17
|
12 |
Kathryn E. Reynolds, Victoria Krasovska, Angela L. Scott. Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3. Journal of Neuroimmunology 2021; 361: 577745 doi: 10.1016/j.jneuroim.2021.577745
|
13 |
Bruno K. Podesser, Maximilian Kreibich, Elda Dzilic, David Santer, Lorenz Förster, Sandra Trojanek, Dietmar Abraham, Martin Krššák, Klaus U. Klein, Eva V. Tretter, Christoph Kaun, Johann Wojta, Barbara Kapeller, Inês Fonseca Gonçalves, Karola Trescher, Attila Kiss. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis. Journal of Hypertension 2018; 36(4): 847 doi: 10.1097/HJH.0000000000001628
|
14 |
Kate Herum, Ida Lunde, Andrew McCulloch, Geir Christensen. The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart. Journal of Clinical Medicine 2017; 6(5): 53 doi: 10.3390/jcm6050053
|
15 |
Lili Yu, Zhiwei Feng. The Role of Toll-Like Receptor Signaling in the Progression of Heart Failure. Mediators of Inflammation 2018; 2018: 1 doi: 10.1155/2018/9874109
|
16 |
Weifang Yuan, Wei Zhang, Xiaofang Yang, Liyuan Zhou, Ziwei Hanghua, Kailiang Xu. Clinical significance and prognosis of serum tenascin-C in patients with sepsis. BMC Anesthesiology 2018; 18(1) doi: 10.1186/s12871-018-0634-1
|
17 |
Fiona Bartoli, Elizabeth L. Evans, Nicola M. Blythe, Leander Stewart, Eulashini Chuntharpursat-Bon, Marjolaine Debant, Katie E. Musialowski, Laeticia Lichtenstein, Gregory Parsonage, T. Simon Futers, Neil A. Turner, David J. Beech. Global PIEZO1 Gain-of-Function Mutation Causes Cardiac Hypertrophy and Fibrosis in Mice. Cells 2022; 11(7): 1199 doi: 10.3390/cells11071199
|
18 |
Monika M. Gladka, Bas Molenaar, Hesther de Ruiter, Stefan van der Elst, Hoyee Tsui, Danielle Versteeg, Grègory P.A. Lacraz, Manon M.H. Huibers, Alexander van Oudenaarden, Eva van Rooij. Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Cytoskeleton-Associated Protein 4 as a New Modulator of Fibroblasts Activation. Circulation 2018; 138(2): 166 doi: 10.1161/CIRCULATIONAHA.117.030742
|
19 |
Victoria Krasovska, Laurie C. Doering. Regulation of IL-6 Secretion by Astrocytes via TLR4 in the Fragile X Mouse Model. Frontiers in Molecular Neuroscience 2018; 11 doi: 10.3389/fnmol.2018.00272
|
20 |
Saori Yonebayashi, Kazuko Tajiri, Mari Hara, Hiromitsu Saito, Noboru Suzuki, Satoshi Sakai, Taizo Kimura, Akira Sato, Akiyo Sekimoto, Satoshi Fujita, Ryuji Okamoto, Robert J. Schwartz, Toshimichi Yoshida, Kyoko Imanaka-Yoshida. Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.620541
|
21 |
Zhiyang Wang, Qi Wei, Liang Han, Keqing Cao, Tianfeng Lan, Zhenjie Xu, Yingjuan Wang, Yuan Gao, Jing Xue, Fei Shan, Jun Feng, Xin Xie. Tenascin‐c renders a proangiogenic phenotype in macrophage via annexin II. Journal of Cellular and Molecular Medicine 2018; 22(1): 429 doi: 10.1111/jcmm.13332
|
22 |
Asma Naseem, Hashim Ali. Systems and Synthetic Immunology. 2020; : 183 doi: 10.1007/978-981-15-3350-1_7
|
23 |
Jamie L. Todd, Scott M. Palmer. Danger signals in regulating the immune response to solid organ transplantation. Journal of Clinical Investigation 2017; 127(7): 2464 doi: 10.1172/JCI90594
|
24 |
Zheng Xiao, Bin Kong, Hongjie Yang, Chang Dai, Jin Fang, Tianyou Qin, He Huang. Key Player in Cardiac Hypertrophy, Emphasizing the Role of Toll-Like Receptor 4. Frontiers in Cardiovascular Medicine 2020; 7 doi: 10.3389/fcvm.2020.579036
|
25 |
Yucai Wang, Guangfu Wang, Hao Liu. Tenascin-C: A Key Regulator in Angiogenesis during Wound Healing. Biomolecules 2022; 12(11): 1689 doi: 10.3390/biom12111689
|
26 |
Wei Xiao, Lan Wang, John Howard, Ravindra Kolhe, Amyn M. Rojiani, Mumtaz V. Rojiani. TIMP-1-Mediated Chemoresistance via Induction of IL-6 in NSCLC. Cancers 2019; 11(8): 1184 doi: 10.3390/cancers11081184
|
27 |
Kyoko Imanaka-Yoshida. Tenascin-C in Heart Diseases—The Role of Inflammation. International Journal of Molecular Sciences 2021; 22(11): 5828 doi: 10.3390/ijms22115828
|
28 |
Rui Song, Lubo Zhang. Cardiac ECM: Its Epigenetic Regulation and Role in Heart Development and Repair. International Journal of Molecular Sciences 2020; 21(22): 8610 doi: 10.3390/ijms21228610
|